Guidelines for Cervical Cancer Screening and Management - Pearls and Perils

Course overview

A standard approach to managing patients with abnormal cervical cytology and cervical cancer precursors was initially developed by ASCCP in 2001. Since then, our understanding of cervical disease has advanced, and screening has changed. Cytologists would benefit from guidance on how to incorporate the newly developed risk-based management guidelines into their routine practice. Attendees will learn the risk estimates based on patient characteristics and current and prior test results. In addition, current screening strategy has shifted to primary HPV as the preferred method. The impact of primary HPV screening will be presented. After this webinar, the attendees will understand the current screening and management guidelines in cervical cancer screening. Presenter(s): Eric C. Huang, MD, PhD